| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |